Related Experiment Video
Updated: Aug 17, 2026

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
Published on: February 22, 2015
Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis
Ee Tuan Lim1, Gavin Giovannoni
1University College London, Department of Neuroinflammation, Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Abstract:
Multiple sclerosis is an organ-specific autoimmune disease, characterized pathologically by cell-mediated inflammation, demyelination and variable degrees of axonal loss. Although inflammation is considered central to the pathogenesis of multiple sclerosis, to date, the only licensed and hence widely used multiple sclerosis immunotherapies are interferon-beta, glatiramer acetate and mitoxantrone. This review discusses the immunopathogenesis of multiple sclerosis, focusing on a number of emerging immunotherapies. A number of new approaches likely to manipulate the immunopathogenesis of multiple sclerosis and which may ultimately allow for the development of more effective immunotherapy are also highlighted.
More Related Videos
Related Concept Videos
Multiple Sclerosis l: Introduction
Tumor Immunotherapy
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cell-mediated Immune Responses
Microorganisms in Medicine and Therapeutics

